Suppr超能文献

新型夜间指标在伴有高心血管事件风险的 OSA 患者中预后价值较低:SAVE 研究的事后分析。

Low Prognostic Value of Novel Nocturnal Metrics in Patients With OSA and High Cardiovascular Event Risk: Post Hoc Analyses of the SAVE Study.

机构信息

Heart Rhythm Disorders (CHRD), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia; Department of Cardiology, Maastricht University Medical Centre, Maastricht, Cardiovascular Research Institute Maastricht (CARIM), University Maastricht, Maastricht, The Netherlands; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Adelaide Institute for Sleep Health (AISH), College of Medicine and Public Health, Flinders University, Adelaide, Australia.

出版信息

Chest. 2020 Dec;158(6):2621-2631. doi: 10.1016/j.chest.2020.06.072. Epub 2020 Jul 14.

Abstract

BACKGROUND

Traditional methods for the quantification of OSA severity may not encapsulate potential relationships between hypoxemia in OSA and cardiovascular risk.

RESEARCH QUESTION

Do novel nocturnal oxygen saturation (Spo) metrics have prognostic value in patients with OSA and high cardiovascular event risk?

STUDY DESIGN AND METHODS

We conducted post hoc analyses of the Sleep Apnea Cardiovascular Endpoints (SAVE) trial. In 2687 individuals, Cox proportional hazards models that were stratified for treatment allocation were used to determine the associations between clinical characteristics, pulse oximetry-derived metrics that were designed to quantify sustained and episodic features of hypoxemia, and cardiovascular outcomes. Metrics included oxygen desaturation index, time <90% Spo, average Spo for the entire recording (mean Spo), average Spo during desaturation events (desaturation Spo), average baseline Spo interpolated across episodic desaturation events (baseline Spo), episodic desaturation event duration and desaturation/resaturation-time ratio, and mean and SD of pulse rate.

RESULTS

Neither apnea-hypopnea index, oxygen desaturation index, nor any of the novel Spo metrics were associated with the primary SAVE composite cardiovascular outcome. Mean and baseline Spo were associated with heart failure (hazard ratio [HR], 0.81; 95% CI, 0.69-0.95; P = .009; and HR, 0.78; 95% CI, 0.67-0.90; P = .001, respectively) and myocardial infarction (HR, 0.86; 95% CI, 0.77-0.95; P = .003; and HR, 0.81; 95% CI, 0.73-0.90; P < .001, respectively). Desaturation duration and desaturation/resaturation time ratio, with established risk factors, predicted future heart failure (area under the curve, 0.86; 95% CI, 0.79-0.93).

INTERPRETATION

Apnea-hypopnea index and oxygen desaturation index were not associated with cardiovascular outcomes. In contrast, the pattern of oxygen desaturation was associated with heart failure and myocardial infarction. However, concomitant risk factors remained the predominant determinants for secondary cardiovascular events and thus deserve the most intensive management.

摘要

背景

传统的阻塞性睡眠呼吸暂停(OSA)严重程度的量化方法可能无法包含 OSA 中的低氧血症与心血管风险之间的潜在关系。

研究问题

新型夜间血氧饱和度(Spo)指标在伴有高心血管事件风险的 OSA 患者中有预后价值吗?

研究设计和方法

我们对睡眠呼吸暂停心血管终点(SAVE)试验进行了事后分析。在 2687 名患者中,使用分层治疗分配的 Cox 比例风险模型来确定临床特征、旨在量化低氧血症持续和发作特征的脉搏血氧仪衍生指标与心血管结局之间的关联。指标包括氧减指数、时间<90%Spo、整个记录的平均 Spo(平均 Spo)、减饱和事件期间的平均 Spo(减饱和 Spo)、在发作性减饱和事件之间插值的平均基线 Spo(基线 Spo)、发作性减饱和事件持续时间和减饱和/复氧时间比,以及平均脉搏率和标准差。

结果

无论是呼吸暂停-低通气指数、氧减指数还是任何新型 Spo 指标都与 SAVE 主要复合心血管结局无关。平均 Spo 和基线 Spo 与心力衰竭(风险比 [HR],0.81;95%CI,0.69-0.95;P =.009;和 HR,0.78;95%CI,0.67-0.90;P =.001)和心肌梗死(HR,0.86;95%CI,0.77-0.95;P =.003;和 HR,0.81;95%CI,0.73-0.90;P <.001)有关。与既定危险因素一起,低氧饱和度持续时间和低氧饱和度/复氧时间比预测未来心力衰竭(曲线下面积,0.86;95%CI,0.79-0.93)。

解释

呼吸暂停-低通气指数和氧减指数与心血管结局无关。相比之下,氧饱和度下降的模式与心力衰竭和心肌梗死有关。然而,伴随的危险因素仍然是二级心血管事件的主要决定因素,因此需要最集中的管理。

相似文献

引用本文的文献

6
..
Heliyon. 2024 Apr 16;10(8):e29494. doi: 10.1016/j.heliyon.2024.e29494. eCollection 2024 Apr 30.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验